VI. HIV Treatment in HIV/HCV Coinfection
ثبت نشده
چکیده
There are many unresolved questions regarding treatment of HIV in people coinfected with HIV and HCV. There are no United States treatment guidelines created specifically for HIV/HCV coinfection. This creates confusion among coinfected people and their clinicians, and variations in patient care. The optimal sequencing of treatment for HIV and HCV is unclear. Treating HIV first may prevent HCV disease progression by preserving the immune system; however, some studies have reported a blunted immune response to antiretroviral therapy in coinfected persons (Greub 2000; Law 2002; Torriani 2001; Zala 2004).
منابع مشابه
HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates
Background: HCV/HIV coinfection in people who inject drugs is a public health issue, which presents a variety of challenges to healthcare providers. The determinants of HCV/HIV coinfection in this population are nonetheless not well known. The aim of the present study is to identify the factors associated with HCV/HIV coinfection in people who inject drugs and enter drug-related treatment. Meth...
متن کاملTreatment of hepatitis C in patients with HIV.
Impact of HIV Coinfection in Persons with Chronic Hepatitis C Infection: In the United States, approximately 5 to 10 percent of patients with chronic hepatitis C (HCV) infection are coinfected with HIV. Coinfection with HIV accelerates the progression of hepatic fibrosis and results in a more aggressive course of liver disease (Figure 1). Cirrhosis has been observed to occur 12 to 16 years earl...
متن کاملHBV and HCV Coinfection among HIV/AIDS Patients in the National Hospital of Tropical Diseases, Vietnam
Aim. To examine prevalence and characterization of HBV and HCV coinfection among HIV/AIDS patients. Methods. This cross-sectional, retrospective study analyzed 724 HIV/AIDS patients in the HIV clinic at the National Hospital of Tropical Diseases (NHTD), from 5/2005 to 4/2011. Results. The prevalence of HBV, HCV, and HIV coinfection was 50.3% (364/724), of which HbsAg, HCV, and both of HbsAg, an...
متن کاملBreaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.
The majority of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection occurs among persons who inject drugs. Rapid improvements in responses to HCV therapy have been observed, but liver-related morbidity rates remain high, given notoriously low uptake of HCV treatment. Advances in HCV therapy will have a limited impact on the burden of HCV-related disease at the population-...
متن کاملHIV/HCV coinfection model: a fractional-order perspective for the effect of the HIV viral load
We study the burden of the HIV viremia and of treatment efficacy in the severity of the patterns of the HIV/HCV coinfection. For this, we derive a simple non-integer-order (fractional-order) model for the coinfection dynamics. Fractional-order models have been proved in the literature to provide good fits to real data from patients suffering from several diseases, such as HIV, dengue fever, and...
متن کامل